Clinical Trial Update: Postoperative Immune Maintenance Therapy for Esophageal Squamous Cell Carcinoma After Radical Resection [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating postoperative immune maintenance therapy for esophageal squamous cell carcinoma after radical resection is in progres…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Snippet

Sponsor: Fujian Medical University Union Hospital | Conditions: Esophageal Squamous Cell Carcinoma Thoracic Stage II, Esophageal Squamous Cell Carcinoma Thoracic Stage III | Phase 3 | Status: UNKNOWN